halothane has been researched along with Mucopolysaccharidosis I in 1 studies
Mucopolysaccharidosis I: Systemic lysosomal storage disease caused by a deficiency of alpha-L-iduronidase (IDURONIDASE) and characterized by progressive physical deterioration with urinary excretion of DERMATAN SULFATE and HEPARAN SULFATE. There are three recognized phenotypes representing a spectrum of clinical severity from severe to mild: Hurler syndrome, Hurler-Scheie syndrome and Scheie syndrome (formerly mucopolysaccharidosis V). Symptoms may include DWARFISM; hepatosplenomegaly; thick, coarse facial features with low nasal bridge; corneal clouding; cardiac complications; and noisy breathing.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The patient's cardiac insufficiency and chronic bronchitis made a balanced anesthesia with reduced dosage of rapifen and halothane necessary." | 1.28 | [Difficult intubation and anesthesia in Pfaundler-Hurler disease]. ( Falk, K; Gross, H; Zinganell, K, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Falk, K | 1 |
| Gross, H | 1 |
| Zinganell, K | 1 |
1 other study available for halothane and Mucopolysaccharidosis I
| Article | Year |
|---|---|
[Difficult intubation and anesthesia in Pfaundler-Hurler disease].
Topics: Adjuvants, Anesthesia; Alfentanil; Anesthesia, Inhalation; Child; Female; Fentanyl; Halothane; Human | 1989 |